The core activity of Primopus AG is the development and manufacture of pharmaceutical active ingredients and intermediates as a Contract Development and Manufacturing Organization (CDMO). They offer services such as process development, manufacturing and backward integration of pharmaceutical active ingredients, including the production of phosphoramidites and Fmoc amino acids.
AI-generated
Offering
Products & services
Industry:Pharmaceutical Industry
Outbound Leads by COHAGA
Looking for direct email addresses and phone numbers?
Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.
Develops and optimizes chemical processes for NCEs, intermediates and RSMs; route scouting, process optimisation, analytical method development, impurity identification, scale-up and technology transfer.
Manufacturing
Manufacturing of API ingredients, innovator intermediates and APIs in Basel, with GMP infrastructure, reactor capacity, DCS automation, digital GMP document management and scale-up support from Goa.
RSMs
Production of complex RSMs in a GMP environment, following ICH Q7 guidance, with closed manufacturing, impurity control and support for drug-substance supply chains.
Backward Integration
Backward integration of building blocks and custom fine chemicals through connected Indian sites, supporting critical custom building blocks for NCE development, launch and commercial supply.
Phosphoramidites
Development and supply of phosphoramidites under the Amideus brand, supported by Basel manufacture, backward integration and cGMP production for oligonucleotide-related demand.
Knowledge
No knowledge articles yet
Once Primopus AG has claimed this profile, we'll publish editorial articles and case studies here together.